July 2021 Test Bulletin
July 8, 2021
Alverno Laboratories has made updates regarding Prostate Health Index (PHI) testing, now sending all samples to ARUP Laboratories, with testing protocols remaining unchanged but requiring serum specimens to be separated and frozen prior to submission. Additionally, Alverno Laboratories is updating its LCMS drug confirmation testing to provide lower levels of detection and detect additional analytes, improving diagnostic accuracy. These updates aim to enhance testing efficiency and accuracy, ensuring optimal patient care.